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A B S T R A C T
Pathology archives with linked clinical data are an invaluable resource for translational research, with the
limitation that most cancer samples are formalin-fixed paraffin-embedded (FFPE) tissues. Therefore, FFPE tissues
are an important resource for genomic profiling studies but are under-utilised due to the low amount and quality
of extracted nucleic acids. We profiled the copy number landscape of 356 breast cancer patients using DNA
extracted FFPE tissues by shallow whole genome sequencing. We generated a total of 491 sequencing libraries
from 2 kits and obtained data from 98.4% of libraries with 86.4% being of good quality. We generated libraries
from as low as 3.8 ng of input DNA and found that the success was independent of input DNA amount and
quality, processing site and age of the fixed tissues. Since copy number alterations (CNA) play a major role in
breast cancer, it is imperative that we are able to use FFPE archives and we have shown in this study that sWGS is
a robust method to do such profiling.
1. Introduction
Comparative Genomic Hybridisation (CGH) (Kallioniemi et al.,
1992) has had a significant impact in the study of cancer genomes.
Chromosomal regions gained or lost in the tumor could be easily vi-
sualised by hybridization onto normal human metaphase spreads, al-
lowing characterisation of genome-wide copy number alterations
(CNA) in tumours (Kallioniemi et al., 1992). Microarrays with DNA
probes (cloned DNA or oligonucleotides) spotted onto glass slides re-
presenting the entire genome soon replaced normal chromosomes
(Pinkel et al., 1998) making it faster and easier to profile. The im-
portance of characterizing somatic CNAs in cancer is now well estab-
lished, with a recent TCGA pan-cancer analysis showing that human
tumours can be classified into mutation driven (M-class) or copy-
number driven (C-class) subtypes. Breast cancer is a C-class cancer type
(Ciriello et al., 2013) and we have previously shown that CNAs are the
main determinants of the expression architecture of breast cancers.
Using gene expression driven in cis by CNAs, we have generated a new
molecular taxonomy of breast cancer with 10 genomic driver-based
subtypes termed Integrative Clusters. The samples used in this analysis
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were derived from the METABRIC cohort, which encompassed a large
biobank of fresh frozen tumor samples collected across five major
teaching hospitals in the UK and Canada (Curtis et al., 2012).
Formalin-fixed paraffin-embedded (FFPE) tissue samples are more
routinely collected and hence more representative of cancer in the
general population. These FFPE archives are a valuable resource for
molecular profiling in cancer research. Whilst the fixation process is
essential to protect cellular morphology and protein expression, it is
detrimental to nucleic acids and results in their chemical modification
and degradation. As a result, extraction of DNA from FFPE tissues re-
sults in lower yields when compared to extraction from fresh frozen
tissues. DNA extracted from FFPE works well for downstream applica-
tions using polymerase chain reaction (PCR), particularly for small size
amplicons (< 300 base pairs), but for other applications, including
microarray based CGH, where efficient labelling of the DNA is depen-
dent on its integrity, its use is more challenging. There have been
several studies describing different methods for DNA extraction
(Janecka et al., 2015), quality control (van Beers et al., 2006; Dang
et al., 2016), labelling (Salawu et al., 2012) and other optimisation
protocols (Hosein et al., 2013) to improve the performance of FFPE
DNA on microarrays. In the past, we have tried to profile CNAs using
FFPE DNA on microarrays with limited success. Only Illumina Infinium
and Molecular Inversion Probe (MIP, Affymetrix) arrays yielded good
results but these required good quality and at least 200 ng of DNA
(Iddawela et al., 2017).
Next generation sequencing has revolutionised cancer genomics. It
is now relatively easy and inexpensive to sequence an entire genome.
However, as with microarrays, the robustness of the results obtained
are dependent on the quality of the input DNA. Two recent studies have
demonstrated the feasibility of doing shallow whole-genome sequen-
cing (sWGS) for CNA profiling using DNA extracted from FFPE tissue
material (Scheinin et al., 2014; Kader et al., 2016). The first report used
250 ng of DNA from FFPE tissues and a breast cancer cell line to pro-
duce libraries and developed an analytical method for sWGS. The
second study compared several sequencing library production kits and
reported generating successful sequencing libraries with low input DNA
in a small number of FFPE samples.
Here we present extensive sWGS data generated from DNA ex-
tracted from FFPE breast cancer samples to describe steps to ensure
successful libraries.
2. Materials
2.1. Specimen collection
FFPE tissue samples from invasive breast cancer patients diagnosed
between 1997 and 2014 were obtained from several tumor repositories:
Addenbrooke's Hospital in Cambridge (n=62), a consortium of hos-
pitals participating in clinical trials (GEICAM) in Spain (n=172), and
Samsung Medical Center in South Korea (n=122). In some cases, we
extracted DNA from adjacent normal (n= 15) and DCIS (n=115)
samples. Some of the clinical trials samples were biopsies taken at di-
agnosis (n= 107) and/or surgery (n= 106) where 41 are paired. All
tumor samples were collected with informed patient consent and their
use for genomics profiling had ethics approval from the institutional
review board for each of the biobanks (Cambridge: REC ref. 07/H0308/
161; South Korea: 2014-10-041; Spain: NCT00432172 &
NCT00841828). Detailed information on the sample cohort is collated
in Table 1.
2.2. DNA extraction and quality control
DNA was extracted from either one mm cores punched from tissue
blocks or from 10×30 μm sections (Cambridge and Korea), or 4-
6× 10 μm sections (Spain) from FFPE blocks, using Qiagen QIAmp
DNeasy Kits (Qiagen, Germany) according to the manufacturer's
instructions. All DNA samples were quantified fluorometrically using
the Qubit dsDNA High Sensitivity Quantification Reagent
(ThermoFisher, USA). The DNA quality was assessed using Illumina's
FFPE QC kit, a quantitative PCR (q-PCR) assay. All test DNAs and the
template control provided in the kit (ACD1) were diluted to 0.25 ng/μl
and PCR reactions set up in triplicate as per manufacturer's instructions.
DNA quality was quantified as the difference between the Ct (cycle
threshold) value of the test FFPE-extracted DNA against the Ct value of
the control DNA template.
Table 1
Features of input DNA and libraries generated from FFPE blocks collected at
three different sites. Data provided in minimum-maximum range and median in
brackets.
Cohort Cambridge Korea Spain
Patients 62 122 172
Age (years) 2–19 (12.4) 3–8 (6.4) 9–10(9)
DNA quality (ΔCt) −0.3–8.1 (3.5) 1–17.1 ⁎ (5.7) −3.2-7.8 (3.5)
Fragment size (bp) 217–324 (247.5) 197–288⁎ (236) 180–251⁎ (225)
Library yield (nM) 0–77 (17.3) 0–925 (12.3) 0.18–278 (13.8)
Good quality libraries
(%)
48 (87.3) 48 (97.1) 163 (74.8)
Age= years since blocks were generated. ΔCt= difference between the cycle
threshold of test to the control template ACD1 provided in the kit. ng= na-
nogram, PCR=polymerase chain reaction, bp= base pairs, nM=nanomoles.
⁎ Denotes the site where there is a significant difference to the index group
(ie Cambridge).
Input DNA
Quantify by Qubit
Qualify by qPCR 
using ILMN FFPE QC kit
Low ΔCt (<10)
- fragment more
- less input DNA
High ΔCt (>10)
- fragment less
- more input DNA
Bioanalyzer
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amount for sequencing 
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Production
For Failed libraries 
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Re-generate libraries
Fig. 1. Overall Design: Schematic showing the workflow to ensure successful
shallow whole genome sequencing (sWGS) libraries.
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2.3. DNA fragmentation
DNA samples of different concentrations (4-500 ng) were diluted in
water to a final volume of 15 μl in Covaris microTUBE-15 8 strip tubes
(Covaris, USA) and fragmented to an average size distribution of 150-
180 bp with Covaris LE220 Focused Ultrasonicator with Adaptive
Focused Acoustics technology. The following parameters were used for
shearing: Peak Incident Power: 180W; Duty Factor: 30%; Cycles per
Burst: 50; with the fragmentation time: 250 s for DNA with ΔCt<10,
and 200 s for DNA with ΔCt ≥10.
2.4. Sequencing library generation
Sequencing libraries were generated using either the beta testing
version of the Illumina FFPE TruSEQ kit (ILMN, libraries= 45) or the
Rubicon Genomics Thruplex DNASeq (RGT, libraries= 446), as per
manufacturer's instructions. For four samples, we generated sequencing
libraries using both kits to compare their performance (Supplementary
Fig. 1a–b). The sample metrics for both kits are presented in
Supplementary Table 1.
The ILMN libraries were generated manually whilst RGT libraries
were generated either on the Agilent Bravo (n=228) or manually
(Spain, n= 218). Final libraries were purified using magnetic beads
(Agencourt SPRI beads, Becton Dickinson, USA) and eluted libraries
were quantified using Kapa Library Quantification kit (Roche Life
Technologies, USA). Fragment size distributions were analysed utilising
a 2100 Bioanalyzer with a DNA High Sensitivity kit (Agilent
Technologies, USA). Two nanomoles (nM) of each library were pre-
pared and 48 samples were pooled in one lane for sequencing on a
HiSeq4000 (Illumina, USA). The pools were re-quantified and normal-
ised to 10 nM. Single end sequencing was conducted for 50 cycles,
generating on average 4.3×108 reads per lane.
2.5. Bioinformatics
Alignment against the GRCh 37 assembly of the human genome was
performed using BWA ver. 0.7.9 (Li and Durbin, 2009) or NovoAlign
ver. 3.2.13 (NovoCraft, Malaysia). PCR and optical duplicates were
identified using Picard tools (https://broadinstitute.github.io/picard)
or Novosort (NovoCraft, Malaysia). Circular binary segmentation on the
aligned files was performed in 100 kb windows using the QDNAseq R
package available on Bioconductor, which corrects for mappability and
GC content (Scheinin et al., 2014). All statistical analyses were per-
formed in R using the functions lm() for fitting linear models and t-test()
for Welch two-sample t-test.
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Fig. 2. Categorisation of copy number profiles.
A. Examples of QDNASEQ copy number plots scored as Very Good, Good, Intermediate and Poor. Failed libraries had very few reads and are not shown. Green dots
represent regions of gains/amplifications and red dots represent regions of loss/deletion. B. Boxplots showing increasing measured standard deviations with de-
creasing libraries'qualities. Dots represent individual samples within each category.
VG=very good, G=good, I= intermediate, P=poor, F= fail.
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Fig. 3. Features of input DNA and libraries generated from blocks less and more than five years.
Dot plots represent the range (minimum-maximum) of observed values for each of the following categories and the red dot represents the median.
A. The quality of input DNA inferred by ΔCt. B. Fragment sizes of the libraries in base pair. C. The library yield in nanomoles.
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Fig. 4. Measured standard deviations from the QDNASEQ copy number plots and associations with the quality of sequencing libraries.
A. Bar charts showing proportion of samples with different input DNA quality (based on ΔCt) in each sequencing quality group. B. Bar charts showing proportion of
samples from FFPE blocks of different fragment sizes in each sequencing quality group. C. Bar charts showing proportion of samples with different amount of input
DNA in each sequencing quality group.
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3. Results
The majority of the FFPE samples available were core biopsies
collected as part of a neoadjuvant clinical trial (GEICAM/2006-03,
n=107) yielding low amounts of DNA (range= 4–61 ng, median
30 ng). Therefore, to successfully generate libraries for CNA profiling
using limited input DNA, we needed to understand how different
variables could influence the quality of libraries and steps that can be
taken to ensure good sequencing results (Fig. 1).
3.1. Assessment of the copy number plots
We examined the copy number plots by manual inspection and
categorised them based on the variance in the CN data for each case
into categories: “Very Good”, “Good”, “Intermediate” and “Poor”
(Fig. 2a). We also used QDNAseq (Scheinin et al., 2014) which calcu-
lates the expected (estimated from read depth) and measured (using
read depth and influenced by DNA quality) standard deviation of the
summarised reads, as a measure of variance. Both measures increased
as the quality of library decreased and validated our categorisation of
library quality (measured standard deviation shown in Fig. 2b).
3.2. Assessment of different sequencing kits
We tested two kits (Illumina FFPE TruSEQ kit and Rubicon
Genomics Thruplex DNASeq) using four FFPE samples to generate se-
quencing libraries and found comparable results (Supplementary
Fig. 1a–b). The CNA profiles obtained using DNA processed with the
ILMN kit had less variance (noise) than those processed using the RGT
kit however the ILMN libraries were generated using more input DNA
(200-500 ng (ILMN) versus 50 ng (RGT)) and were sequenced deeper
(average coverage 0.9× (ILMN) versus 0.08× (RGT)). For a more
comparable evaluation, we down-sampled ILMN sequencing data to a
similar read depth as RGT; this showed comparable copy number pro-
file qualities between the two library preparation technologies.
In theory, increasing the sequencing depth should improve the copy
number results by reducing the variance. We examined this by in-
creasing the sequencing depth of 23 RGT kit libraries which had less
reads (from 0.08× up to 0.15×) and found improvement in the data
quality in 20 out of 23 libraries (examples shown in Supplementary
Fig. 2a). To examine the association between sequencing depth and
variance, we down-sampled the number of reads (in steps of 1×106
reads) for six libraries with high read counts (up to 24×106 reads). We
found a significant improvement in the quality of copy number plots
with increasing number of reads (p < 2.2e-16; Supplementary Fig. 2b).
It is interesting to note that the noise reduction levels off at approxi-
mately 7× 106 reads suggesting that increasing the read depth> 7
×106 reads provides little benefit to variance reduction.
3.3. Performance of sWGS for copy number profiling using the RGT kit
Due to the limited amount of DNA available for most samples, we
chose the RGT kit as it required less input DNA due to fewer processing
steps, in particular purifications. Sequencing libraries were generated
from as little as 3.8 ng of DNA, and out of 16 libraries prepared
from<10 ng of DNA, only one failed, 13 generated good quality CNA
plots, and 2 generated intermediate quality CNA plots. Information for
all the libraries generated are summarised in Supplementary Table 3.
3.4. Recovery of under-performing RGT libraries
Eight (1.8%) libraries failed and 12 (2.7%) generated poor quality
libraries out of 446 libraries. To recover some of these failed/poor
samples, we prepared fresh libraries from samples with sufficient DNA
(n= 6) or repeated the sequencing using three-fold more library ma-
terial for samples with insufficient DNA to generate new libraries
(n= 8). Thirteen of these new/re-sequenced libraries generated good
quality data. The one repeat sample that failed was from the re-se-
quencing group. Consequently, only two out of 446 RGT libraries
(taking into consideration the repeated libraries and re-sequencing)
failed, resulting in a 99.5% success rate. Good sWGS data produced
from 379/446 (84.9%) samples.
3.5. Association between FFPE storage time, site, and sequencing quality
The FFPE samples were collected from three different tissue banks,
spanning 20 years (Table 1). The effect of storage time on the DNA
extracted was analysed (Fig. 3). DNA from older FFPE blocks
(> 5 years) was generally of poorer quality: higher ΔCt values, shorter
fragment size, generating lower yield sequencing libraries. We com-
pared the quality metrics for each banking site and found that overall
FFPE samples from different sites were comparable (Table 1 and Sup-
plementary Fig. 3).
3.6. Association between input DNA characteristics and sequencing library
yield
We used the Illumina FFPE QC kit, a quantitative-PCR assay to es-
timate the quality of FFPE-extracted DNA. This assay measures the
difference in Ct (cycle threshold) value of the test FFPE-extracted DNA
against the Ct value of the control DNA template provided in the kit.
Increasing ΔCt values indicate decreasing DNA quality with Illumina
quality thresholds set at: ΔCt < 1.5 denotes high quality (HQ),
ΔCt < 3.0 denotes medium quality (MQ), and ΔCt > 3 denotes low
quality (LQ) DNA. The Illumina DNA-input recommendations for sWGS
are 50 ng DNA with HQ DNA, 200 ng with MQ DNA, and exclusion of
LQ DNA. Using the ILMN kit, we could generate good quality sWGS
using 50 ng HQ and MQ DNA, and 200-500 ng of LQ DNA.
Unsurprisingly, for eight samples with paired libraries generated from
50 ng and 200 or 500 ng of input DNA using the ILMN kit, we found
that the sequencing library yields generated with more DNA was sig-
nificantly higher than when using only 50 ng (p-value: 0.000265;
Supplementary Fig. 3a). This is an important consideration if these li-
braries were destined for downstream target enrichment assays for
mutation detection that require 500 ng of library material. Data from all
the generated ILMN libraries (n=45) showed a library yield that
Table 2
Features of input DNA and libraries for the different categories of copy number data. Data provided in minimum-maximum range and median values in brackets.
Quality DNA input (ng) DNA quality (ΔCt) Library yield (nM) Fragment size (bp) Observed SD
VG 3.8–100 (30.3) −0.3-12.7 (4.4) 0.28–245.1 (16.1) 180–288 (235) 0.01–0.132 (0.097)
G 4.3–107 (35.9)⁎ 1–17.1 (4.2) 0.18–139.7 (11.3) 195–324 (229)⁎ 0.0789–0.144 (0.1105)⁎
I 4–59 (33.1) −3.2-6.3 (3.5)⁎ 1.06–924.8 (16.0)⁎ 191–258 (231)⁎ 0.0739–0.24 (0.127)⁎
P 14.7–50 (28.7) 2–11.3 (4.9) 0–55.63 (8.7) 187–243 (219)⁎ 0.119–0.329 (0.171)⁎
F 4.8–51.1 (25.2) 1.9–8.2 (4.9) 0–179.6 (8.2) 204–244 (225) 0.388–0.826 (0.528)⁎
ΔCt=difference between the cycle threshold of test to the control template ACD1 provided in the kit, ng=nanogram, bp=base pairs, nM=nanomoles,
SD= standard deviation.
⁎ Denotes the site where there is a significant difference to the index group (ie Cambridge).
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averaged 5.6 nM using 50 ng FFPE-extracted DNA, which was sig-
nificantly less than with libraries made with more input DNA (200 ng,
23.6 nM, Welch Two Sample t-test, p= 5.24e−06; 500 ng: 23.0 nM,
Welch Two Sample t-test, p= 0.0121). There was no difference in li-
brary yield when using either 200 or 500 ng of DNA (Welch Two
Sample t-test, p= 0.2401). This is probably due to the quality of the
input DNA as libraries produced from 200 ng of DNA had lower ΔCt
values (better quality) than those using 500 ng (Welch Two Sample t-
test, p= 0.0179, Supplementary Fig. 4a–c).
Using the RGT kit, we found no correlation between amount of
input DNA and sequencing library yield (r2=−0.002, p=0.81). This
is probably due to the fewer library-washing steps using the RGT kit (six
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washing steps in the ILMN protocol versus one in RGT).
3.7. Association between input DNA characteristics and sequencing library
quality
Next we sought to determine if sequencing quality was influenced
by the nature of the input DNA by looking at the proportion of samples
from all quality (ΔCt) groups (Fig. 4a), fragment sizes (Fig. 4b) and
different input groups (Fig. 4c) in each of the sequencing quality ca-
tegories. Reassuringly, we found no biases in sampling that contributed
to the sequencing quality. In other words, each copy number plot
quality group had samples from all DNA quality (ΔCt) groups, fragment
sizes and input quantity groups, suggesting that we could generate good
quality libraries from most of our FFPE DNA regardless of these fea-
tures.
Using our copy number output categorisation scoring, we examined
if quality of the libraries (analysed as “all sequencing quality groups”
versus “very good”) can be attributed to the different features of the
input DNA and library yields (Table 2, Fig. 5). We found that the
quantity of template was only significantly different in the good quality
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libraries. Meanwhile, the quality of input DNA was significantly dif-
ferent in the intermediate libraries only when compared to the “very
good” libraries. Therefore, the lesser quality sequencing libraries (I, P
and F) cannot be attributed simply to either quantity or quality of the
template DNA. The DNA fragment sizes, which should reflect the length
of the template as the DNA was sheared under similar conditions, were
found to be significantly different in all groups (progressively becoming
shorter) except the failures. We found that low quality DNA was asso-
ciated with shorter DNA fragments, lower library yield and higher
number of unmapped reads but no association with the total number of
unique reads aligned (Fig. 6a–d). The recovery of most of the poor/
failed libraries described previously, was achieved by either repeating
the library generation or re-sequencing to generate more reads. Con-
sequently, we suspect the poor/failed libraries could be due to a loss of
DNA during the purification steps or that the Q-PCR quantification of
the libraries prior to normalisation, over-estimated the library con-
centration resulting in inadequate amount of library being used for
sequencing. This would explain why by simply increasing the quantity
of libraries for sequencing and reducing the number of samples in a
single pool, ensured adequate read counts and successful sequencing.
4. Discussion
In this study, we have looked at the effect that quantity and quality
of DNA from FFPE tissues has on successful sWGS library preparation
for CN profiling of human breast cancers. Both the quantity and quality
of DNA have always been an important consideration for sample se-
lection and in deciding which genomic application to use. For example,
microarrays require 100 ng–2.5 μg of DNA depending on the resolution
of the arrays whereas PCR based methods require only 10 ng of DNA. In
our hands, we have not had much success in obtaining CN data with
DNA extracted from FFPE DNA using microarrays, especially when the
extracted DNAs are more fragmented and of lower quality (judging
from absorbance ratios of 260 nm to 280 nm and multiplex PCR for
quality control).
Here we have robustly shown that we can generate CN data from
virtually all archived FFPE samples using sWGS. We show good CN
profiling data irrespective of the quality of input DNA, as inferred by
whether it can be amplified with Q-PCR (ΔCt). Previous work has ex-
tensively tested the utility of FFPE DNA for mutation analysis (Astolfi
et al., 2015; De Paoli-Iseppi et al., 2016; Dumur et al., 2015; Holley
et al., 2012; Kerick et al., 2011) but to date no comprehensive study has
shown its use for CN profiling. Since many human cancer types, in-
cluding breast and ovarian cancers, are driven mostly by CNA (C-class)
rather than point mutations or indels (M-class), we believe more effort
should be focussed on characterizing the copy number landscapes of
these cancers (Ciriello et al., 2013). We found sWGS to be very robust in
generating these CN profiles, independently of the kits used, quantity
and quality of DNA. sWGS is also significantly cheaper (~50%) than
microarray-based methods (Supplementary Table 2).
Another advantage of generating sWGS libraries is the ability to use
the same library for targeted sequence enrichment to identify muta-
tions. There have been other methods reported for CN profiling using
DNA extracted from FFPE samples but these methods do not generate
sequencing libraries that can then be used for target enrichment and
sequencing (Hughesman et al., 2016) or if they do, are expensive (Singh
et al., 2016). In addition, sWGS will also serve as a quality control for
the libraries, given its relative low cost when compared to that of
generating targeted sequencing libraries. Only libraries that generate
good CN profiles should be used for target enrichment and mutation
detection (Kinde et al., 2012). Whilst we haven't performed target en-
richment on our FFPE libraries, we expect the performance of these
FFPE libraries for mutation analysis to be similar to that of published
data, including known artefacts caused by formalin-based fixation ef-
fects on the DNA template (De Paoli-Iseppi et al., 2016; Holley et al.,
2012; Carrick et al., 2015; Fassunke et al., 2015; Hadd et al., 2013).
5. Conclusions
We have shown that sWGS is a robust and cost-effective method for
obtaining good quality CN data from FFPE cancer samples, irrespective
of the DNA quality and quantity used. In the case of breast cancer, CN
profiles can be used to stratify breast cancers into one of the 10
Integrative Clusters (Ali et al., 2014), reiterating the importance of
FFPE tumor archives. The methods described here are also of relevance
to other cancers, e.g. ovarian cancers where CN profiling is essential to
characterise their genomic landscapes.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.yexmp.2018.03.006.
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